Skip to main content
SpringerLink
Log in

The Transplant Patient with Cocaine Use Disorder and Attention Deficit/Hyperactivity Disorder

  • Chapter
  • First Online:
Transplant Psychiatry

  • 343 Accesses

Abstract

Given the high prevalence of substance use disorders in the general population and the inevitable ill-effects substances can have directly or indirectly on organs, a large portion of patients that present for transplant evaluation have either a current and/or lifetime history of a substance use disorder. The transplant team is then faced with assessing the patient’s candidacy as it relates to their alcohol or illicit drug use. This case discussion illustrates a patient with cocaine use disorder who, with an ongoing focus on active recovery as well as optimal management of his co-occurring attention-deficit hyperactivity disorder (ADHD), was able to successfully undergo living kidney donor transplantation. Future considerations regarding management of patients with cocaine use disorder in need of organ transplantation should have less emphasis on length of abstinence, but rather addressing factors that will decrease the risk of relapse, including active engagement in substance abuse and psychiatric treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Substance Abuse and Mental Health Services Administration [updated january 7th 2021].

    Google Scholar 

  2. Alzghoul BN, Abualsuod A, Alqam B, Innabi A, Palagiri DR, Gheith Z, et al. Cocaine use and pulmonary hypertension. Am J Cardiol. 2020;125(2):282–8.

    Article  CAS  Google Scholar 

  3. Hobbs WE, Moore EE, Penkala RA, Bolgiano DD, López JA. Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner. Arterioscler Thromb Vasc Biol. 2013;33(6):1230–7.

    Article  CAS  Google Scholar 

  4. Peacock A, Tran LT, Larney S, Stockings E, Santo T Jr, Jones H, et al. All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis. Addiction. 2021;116(4):725–42.

    Article  Google Scholar 

  5. Winhusen T, Theobald J, Kaelber DC, Lewis D. Increased morbidity and mortality in hypertensive patients with substance use disorders: electronic health record findings. J Stud Alcohol Drugs. 2020;81(4):471–8.

    Article  Google Scholar 

  6. Nyenwe EA, Loganathan RS, Blum S, Ezuteh DO, Erani DM, Wan JY, et al. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract. 2007;13(1):22–9.

    Article  Google Scholar 

  7. Morentin B, Ballesteros J, Callado LF, Meana JJ. Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study. Addiction. 2014;109(12):2071–8.

    Article  Google Scholar 

  8. Siniscalchi A, Bonci A, Mercuri NB, De Siena A, De Sarro G, Malferrari G, et al. Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res. 2015;12(2):163–72.

    Article  CAS  Google Scholar 

  9. Milby JB, Conti K, Wallace D, Mennemeyer S, Mrug S, Schumacher JE. Comorbidity effects on cocaine dependence treatment and examination of reciprocal relationships between abstinence and depression. J Consult Clin Psychol. 2015;83(1):45–55.

    Article  Google Scholar 

  10. Pavarin RM, Sanchini S, Tadonio L, Domenicali M, Caputo F, Pacetti M. Suicide mortality risk in a cohort of individuals treated for alcohol, heroin or cocaine abuse: results of a follow-up study. Psychiatry Res. 2021;296:113639.

    Article  Google Scholar 

  11. Tull MT, Trotman A, Duplinsky MS, Reynolds EK, Daughters SB, Potenza MN, et al. The effect of posttraumatic stress disorder on risk-taking propensity among crack/cocaine users in residential substance abuse treatment. Depress Anxiety. 2009;26(12):1158–64.

    Article  Google Scholar 

  12. Roncero C, Ros-Cucurull E, Daigre C, Casas M. Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas Esp Psiquiatr. 2012;40(4):187–97.

    Google Scholar 

  13. Dias AC, Araújo MR, Laranjeira R. Evolution of drug use in a cohort of treated crack cocaine users. Rev Saude Publica. 2011;45(5):938–48.

    Article  Google Scholar 

  14. Lopes-Rosa R, Kessler FP, Pianca TG, Guimarães L, Ferronato P, Pagnussat E, et al. Predictors of early relapse among adolescent crack users. J Addict Dis. 2017;36(2):136–43.

    Article  Google Scholar 

  15. Broos N, Diergaarde L, Schoffelmeer AN, Pattij T, De Vries TJ. Trait impulsive choice predicts resistance to extinction and propensity to relapse to cocaine seeking: a bidirectional investigation. Neuropsychopharmacology. 2012;37(6):1377–86.

    Article  Google Scholar 

  16. Sánchez-Hervás E, Santonja Gómez FJ, Secades Villa R, García-Fernández G, García-Rodríguez O, Zacarés Romaguera F. Psychosocial predictors of relapse in cocaine-dependent patients in treatment. Span J Psychol. 2012;15(2):748–55.

    Article  Google Scholar 

  17. Grella CE, Hser YI, Hsieh SC. Predictors of drug treatment re-entry following relapse to cocaine use in DATOS. J Subst Abuse Treat. 2003;25(3):145–54.

    Article  Google Scholar 

  18. Hyman SM, Paliwal P, Chaplin TM, Mazure CM, Rounsaville BJ, Sinha R. Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend. 2008;92(1–3):208–16.

    Article  CAS  Google Scholar 

  19. Paliwal P, Hyman SM, Sinha R. Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire. Drug Alcohol Depend. 2008;93(3):252–9.

    Article  CAS  Google Scholar 

  20. Brandt L, Chao T, Comer SD, Levin FR. Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer? Addiction. 2021;116(4):694–710.

    Article  Google Scholar 

  21. Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Pharmacotherapy for cocaine use disorder—a systematic review and meta-analysis. J Gen Intern Med. 2019;34(12):2858–73.

    Article  Google Scholar 

  22. Antonelli M, Fattore L, Sestito L, Di Giuda D, Diana M, Addolorato G. Transcranial Magnetic Stimulation: a review about its efficacy in the treatment of alcohol, tobacco and cocaine addiction. Addict Behav. 2021;114:106760.

    Article  Google Scholar 

  23. Rodrigues LA, Caroba MES, Taba FK, Filev R, Gallassi AD. Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: a systematic review. Pharmacol Biochem Behav. 2020;196:172982.

    Article  CAS  Google Scholar 

  24. De Giorgi R, Cassar C, Loreto D’alò G, Ciabattini M, Minozzi S, Economou A, et al. Psychosocial interventions in stimulant use disorders: a systematic review and qualitative synthesis of randomized controlled trials. Riv Psichiatr. 2018;53(5):233–55.

    Google Scholar 

  25. Secunda K, Gordon EJ, Sohn MW, Shinkunas LA, Kaldjian LC, Voigt MD, et al. National survey of provider opinions on controversial characteristics of liver transplant candidates. Liver Transpl. 2013;19(4):395–403.

    Article  Google Scholar 

  26. Liang EF, Lim SZ, Tam WW, Ho CS, Zhang MW, McIntyre RS, et al. The effect of methylphenidate and atomoxetine on heart rate and systolic blood pressure in young people and adults with attention-deficit hyperactivity disorder (ADHD): systematic review, meta-analysis, and meta-regression. Int J Environ Res Public Health. 2018;15(8):1789.

    Article  Google Scholar 

  27. Baradhi KM, Pathireddy S, Bose S, Aeddula NR. Methamphetamine (N-methylamphetamine)-induced renal disease: underevaluated cause of end-stage renal disease (ESRD). BMJ Case Rep. 2019;12(9):e230288.

    Article  Google Scholar 

  28. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keefe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998;66(7):956–62.

    Article  CAS  Google Scholar 

  29. Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 2001;71(9):1189–204.

    Article  CAS  Google Scholar 

  30. Bramstedt KA, Jabbour N. When alcohol abstinence criteria create ethical dilemmas for the liver transplant team. J Med Ethics. 2006;32(5):263–5.

    Article  CAS  Google Scholar 

  31. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–95.

    Article  CAS  Google Scholar 

  32. Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003;25(3):125–34.

    Article  Google Scholar 

  33. Sundquist J, Ohlsson H, Sundquist K, Kendler KS. Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study. Psychol Med. 2015;45(5):977–83.

    Article  CAS  Google Scholar 

  34. Oliva F, Mangiapane C, Nibbio G, Berchialla P, Colombi N, Vigna-Taglianti FD. Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Psychiatr Res. 2021;143:587–98.

    Article  CAS  Google Scholar 

  35. Groenman AP, Schweren LJS, Weeda W, Luman M, Noordermeer SDS, Heslenfeld DJ, et al. Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2019;28(9):1213–22.

    Article  Google Scholar 

  36. Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, et al. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry. 2013;203(2):112–9.

    Article  Google Scholar 

  37. Quinn PD, Chang Z, Hur K, Gibbons RD, Lahey BB, Rickert ME, et al. ADHD medication and substance-related problems. Am J Psychiatry. 2017;174(9):877–85.

    Article  Google Scholar 

  38. Manni C, Cipollone G, Pallucchini A, Maremmani AGI, Perugi G, Maremmani I. Remarkable reduction of cocaine use in dual disorder (adult attention deficit hyperactive disorder/cocaine use disorder) patients treated with medications for ADHD. Int J Environ Res Public Health. 2019;16(20):3911.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Sarah Ramsay Andrews

Authors
  1. Sarah Ramsay Andrews
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Ramsay Andrews .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

    Paula C. Zimbrean

  2. Department of Psychiatry, Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  3. Department of Behavioral Health, Inova Fairfax Hospital, George Washington University, Falls Church, VA, USA

    Catherine Crone

  4. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

    Andrea F. DiMartini

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Andrews, S.R. (2022). The Transplant Patient with Cocaine Use Disorder and Attention Deficit/Hyperactivity Disorder. In: Zimbrean, P.C., Sher, Y., Crone, C., DiMartini, A.F. (eds) Transplant Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-15052-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15052-4_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15051-7

  • Online ISBN: 978-3-031-15052-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation